Literature DB >> 22895385

Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season.

.   

Abstract

In 2010, the Advisory Committee on Immunization Practices (ACIP) first recommended annual influenza vaccination for all persons aged ≥6 months in the United States (1). Annual influenza vaccination of all persons aged ≥6 months continues to be recommended. This document 1) describes influenza vaccine virus strains included in the U.S. seasonal influenza vaccine for 2012-13; 2) provides guidance for the use of influenza vaccines during the 2012-13 season, including an updated vaccination schedule for children aged 6 months through 8 years and a description of available vaccine products and indications; 3) discusses febrile seizures associated with administration of influenza and 13-valent pneumococcal conjugate (PCV-13) vaccines; 4) provides vaccination recommendations for persons with a history of egg allergy; and 5) discusses the development of quadrivalent influenza vaccines for use in future influenza seasons. Information regarding issues related to influenza vaccination that are not addressed in this update is available in CDC's Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010 and associated updates (1,2).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895385

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  92 in total

1.  Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.

Authors:  Lisa M Christian; Chloe Beverly; Amanda M Mitchell; Erik Karlsson; Kyle Porter; Stacey Schultz-Cherry; Octavio Ramilo
Journal:  Vaccine       Date:  2017-08-01       Impact factor: 3.641

2.  Current status and uptake of influenza vaccination over time among senior adults in the United States.

Authors:  Peng-Jun Lu; Alissa O'Halloran; Helen Ding; Stacie M Greby; Walter W Williams
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

3.  Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.

Authors:  Julie E Ledgerwood; Zonghui Hu; Pamela Costner; Galina Yamshchikov; Mary E Enama; Sarah Plummer; Cynthia S Hendel; Lasonji Holman; Brenda Larkin; Ingelise Gordon; Robert T Bailer; Donald M Poretz; Uzma Sarwar; Alisha Kabadi; Richard Koup; John R Mascola; Barney S Graham
Journal:  Contemp Clin Trials       Date:  2015-08-12       Impact factor: 2.226

4.  Clinician perspectives on strategies to improve patient maternal immunization acceptability in obstetrics and gynecology practice settings.

Authors:  Paula M Frew; Laura A Randall; Fauzia Malik; Rupali J Limaye; Andrew Wilson; Sean T O'Leary; Daniel Salmon; Meghan Donnelly; Kevin Ault; Matthew Z Dudley; Vincent L Fenimore; Saad B Omer
Journal:  Hum Vaccin Immunother       Date:  2018-02-15       Impact factor: 3.452

5.  IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines.

Authors:  Kouya Yamaki; Takayuki Nakashima; Kenji Miyatake; Yuki Ishibashi; Ayaka Ito; Ayu Kuranishi; Akihito Taguchi; Ayumi Morioka; Midori Yamamoto; Shin Yoshino
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 6.  Traditional and new influenza vaccines.

Authors:  Sook-San Wong; Richard J Webby
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

7.  Substitutions near the hemagglutinin receptor-binding site determine the antigenic evolution of influenza A H3N2 viruses in U.S. swine.

Authors:  Nicola S Lewis; Tavis K Anderson; Pravina Kitikoon; Eugene Skepner; David F Burke; Amy L Vincent
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

Review 8.  Influenza prevention and treatment in transplant recipients and immunocompromised hosts.

Authors:  Michael G Ison
Journal:  Influenza Other Respir Viruses       Date:  2013-11       Impact factor: 4.380

9.  Measuring Preventive Care Delivery: Comparing Rates Across Three Data Sources.

Authors:  Steffani R Bailey; John D Heintzman; Miguel Marino; Megan J Hoopes; Brigit A Hatch; Rachel Gold; Stuart C Cowburn; Christine A Nelson; Heather E Angier; Jennifer E DeVoe
Journal:  Am J Prev Med       Date:  2016-08-10       Impact factor: 5.043

10.  Preventive Care Delivery to Young Children With Sickle Cell Disease.

Authors:  David G Bundy; John Muschelli; Gwendolyn D Clemens; John J Strouse; Richard E Thompson; James F Casella; Marlene R Miller
Journal:  J Pediatr Hematol Oncol       Date:  2016-05       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.